A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia

This publication has 21 references indexed in Scilit:

• Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients
  Kidney International, 1992
• The Treatment of Uraemic Hyperphosphataemia with Calcium Acetate and Calcium Carbonate: A Comparative Study
  Nephrology Dialysis Transplantation, 1991
• The ‘Oral 1,25-Dihydroxyvitamin D3 Pulse Therapy’ in Hemodialysis Patients with Severe Secondary Hyperparathyroidism
  Nephron, 1991
• Soft tissue calcification in pediatric patients with end-stage renal disease
  Kidney International, 1990
• Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal Failure
  New England Journal of Medicine, 1989
• Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.
  Journal of Clinical Investigation, 1989
• Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis
  New England Journal of Medicine, 1986
• Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
  Journal of Clinical Investigation, 1984
• Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
  Journal of Clinical Investigation, 1984
• The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis
  Kidney International, 1973